Fisher Wallace Laboratories on StartEngine | Deal Review

Apr 27, 2021 1 min read
Fisher Wallace Laboratories
Medical Devices for Mood and Sleep

Fisher Wallace Campaign's Highlights

Medical Devices for Mood and Sleep


  • Over 60,000 patients and 10,000 prescribers in the United States, with over $23.3M in lifetime revenue

Clear Path to FDA Approval

  • Three clinical trials were submitted to the FDA on March 19, 2021 to support new approval and clearance; over-the-counter approval has been obtained in Europe, and Medicaid has approved the device in Maine (MaineCare)

Previous Crowdfunding Success

  • Raised over $1M in an oversubscribed Reg CF raise from over 1400+ investors

Did I Invest In Fisher Wallace?

I’m still in the process of writing a full deal report and decide whether or not I will invest in Fisher Wallace. I review 100+ startups on 10+ platforms every month and send a detailed report every Saturday to subscribers of the Angel Notes newsletter (you can join through the form below). See you soon!

Great! Next, complete checkout for full access to Angel Notes.
Welcome back! You've successfully signed in.
You've successfully subscribed to Angel Notes.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.